
|
Home
: News and Events : Event Brings Together Philanthropy, Venture Capital, Medical Research
Event Brings Together Philanthropy, Venture Capital, Medical Research
Date Published: November 10, 2009
Join hundreds of medical research leaders, investors, and decision-makers coming together at the inaugural Partnering for Cures meeting to explore innovative approaches to pursuing high-risk, long-term investments that could lead to therapeutic breakthroughs. This first-of-its-kind meeting, to be held December 1-3 at the Millennium Broadway Hotel in New York City, will:
- feature panels and plenaries that spotlight solutions to decades-long problems facing medical research;
- facilitate connections across sectors through partnering opportunities and networking events designed to link specific therapeutic affinities; and
- cultivate relationships with and learn best practices from drivers and supporters of medical research.
Register now and avail of The Philanthropic Initiative's special discount: 20% off Partnering for Cures Registration. Enter Priority Code TPG79-P4C.
Speakers include:
Decision-makers from the biotechnology and pharmaceutical industries:
- Jeffrey Kindler, Chief Executive Officer and Chairman of the Board, Pfizer
- The Hon. Billy Tauzin, President and Chief Executive Officer, Pharmaceutical Research and Manufacturers of America (PhRMA)
- The Hon. James Greenwood, President and CEO, Biotechnology Industry Organization
- Garry Neil, M.D., Corporate Vice President, Corporate Office of Science and Technology, Johnson & Johnson
Venture philanthropy leaders:
- Robert J. Beall, Ph.D., President and CEO, Cystic Fibrosis Foundation
- Debi Brooks, Co-Founder, Michael J. Fox Foundation
- Kathy Giusti, Founder and CEO, Multiple Myeloma Research Foundation
- Hala Moddelmog, President and CEO, Susan G. Komen for the Cure
Philanthropists who are transforming the medical research enterprise:
- Michael Milken, Chairman, FasterCures/The Center for Accelerating Medical Solutions; Chairman, The Milken Institute
- Debra Black, Founder and Chair, Melanoma Research Alliance
And, some of the most forward-thinking leaders in medical research:
- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases
- Douglas A. Melton, Ph.D., Co-Director, Harvard Stem Cell Institute
- Seth Berkley, M.D., President and CEO, International AIDS Vaccine Initiative
- Anne Wojcicki, Co-Founder and President, 23andMe
Partnering for Cures is convened by FasterCures, the Washington, D.C.-based center of the Milken Institute, that's committed to breaking down the barriers that exist across the research continuum - from basic research to drug development - to clear the path to faster medical progress.
|
|